INGENIOUS
Truking Technology Ltd

Ingenious Media Live Directory

Truking Technology Ltd

Profile typeExhibitor

Official Exhibitor of the BioPharma & Life Sciences Connected Live

Stand: 42

Founded 2000, Truking Technology Limited is a global leader in pharmaceutical equipment and integrated solutions, pioneering intelligent pharma factory R&D. A-share listed, it operates key subsidiaries including Germany’s Romaco Group, Truking Watertown, Sichuan Pharmaceutical Design Institute, Truking Feiyun, Truking Microspheres, Truking SUT, Truking Gene, and Truking Pitide. Global workforce: ~7,000 (~2,000 R&D). Total assets: ~RMB 13.2B. Annual sales: ~USD 1B. Dual HQs in Changsha and Germany anchor three R&D institutes: Changsha Central Tech Research Institute, European Tech Research Institute, and Sichuan Pharmaceutical Design Institute, plus post-doctoral/academician expert workstations. As of Feb 28, 2026: 6,577 domestic patent filings (5,497 granted, incl. 732 valid invention patents); 72 PCT filings (38 granted across US, Russia, India, South Korea, Germany, Indonesia, Japan, Europe). Led 20+ national/industry standards. Products serve ~3,000 clients in 180+ countries/regions; cumulative sales: ~100,000 units. Global market split into five divisions: East Asia & SE Asia; Middle East, Africa & CIS; Europe; Americas; India, NZ & Australia, supported by ~30 localized SSCs. Breakthroughs in Europe/Americas accelerate overseas revenue growth and market share gains. Building the "Truking Biomedical and Life Sciences Industry Chain" targeting high-end biopharma and gene tech to hit a RMB 100B scale. Mission: "Equip global pharmaceutical manufacturing with intelligent wings." Guided by the credo "Be a respected person, make quality products, run a prestigious company" and ethos "Persistence makes excellence," adhering to the tenet: "Value customer’s voices, treat dedicated employees as a solid foundation, and work under the driving forces of goal, responsibility and good results," aiming for top-tier global leadership by ~2030.
Built byRainRocks